FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415798049> ?p ?o ?g. }

• W2415798049 abstract "OBJECTIVE: To systematically explore the relationship between GCH1 mutations and Parkinson disease.BACKGROUND: GTP cyclohydrolase-1, encoded by the GCH1 gene, is an essential enzyme for dopamine production in nigrostriatal cells. Heterozygous loss-of-function mutations in GCH1 are the most common cause of dopa-responsive dystonia, a metabolic disease that classically presents in childhood with generalized dystonia and a dramatic long-lasting response to levodopa.DESIGN/METHODS: We describe clinical, genetic and nigrostriatal dopaminergic imaging findings ([123I]FP-CIT SPECT) of four unrelated pedigrees in which pathogenic GCH1 mutations were identified in patients with classic dopa-responsive dystonia and in family members with adult-onset parkinsonism. The frequency of GCH1 coding or splice-mutation mutations was evaluated in the exome-sequencing data of 1337 Parkinson disease cases without a family of history of dystonia and 5209 ethnicity-matched controls.RESULTS: Dopamine-transporter imaging was abnormal in all parkinsonian patients, indicating Parkinson disease-like nigrostriatal dopaminergic denervation. In the exome sequencing data we identified 11 different heterozygous GCH1 mutations, including four mutations known to cause dopa-responsive dystonia (Q110X, V204I, K224R, M230I), six novel mutations (L92I, T112A, A120S, D134G, R198Q, G217V) and one benign variant (P69L). The frequency of pathogenic and novel non-synonymous coding mutations in GCH1 was significantly higher in cases (7/1337=0.52%) than in controls (8/5209=0·15%; p=0·02; odds ratio 3·4, 95% confidence interval=1·2-9·4). All parkinsonian cases identified with GCH1 mutations fully met the UK Parkinson9s Disease Society Brain Bank clinical diagnostic criteria for Parkinson’s disease.CONCLUSIONS: Our results show that GCH1 mutations should be considered as a novel risk factor for PD. GTP cyclohydrolase-1 deficiency not only leads to biochemical striatal dopamine depletion and dopa-responsive dystonia, but also predisposes to nigrostriatal cell loss. Further insight into GCH1-associated pathogenetic mechanisms will shed light on the role of dopamine metabolism in nigral degeneration and Parkinson disease. Disclosure: Dr. Mencacci has nothing to disclose. Dr. Isaias has nothing to disclose. Dr. Reich has nothing to disclose. Dr. Ganos has nothing to disclose. Dr. Polke has nothing to disclose. Dr. Bras has nothing to disclose. Dr. Hersheson has nothing to disclose. Dr. Pittman has nothing to disclose. Dr. Noyce has nothing to disclose. Dr. Mok has nothing to disclose. Dr. Opladen has nothing to disclose. Dr. Kunstmann has nothing to disclose. Dr. Sidle has nothing to disclose. Dr. Sweeney has nothing to disclose. Dr. Houlden has nothing to disclose. Dr. Sybille has nothing to disclose. Dr. Batla has nothing to disclose. Dr. Munchau has nothing to disclose. Dr. Volkmann has nothing to disclose. Dr. Samnick has nothing to disclose. Dr. Marotta has nothing to disclose. Dr. Zecchinelli has nothing to disclose. Dr. Pezzoli has nothing to disclose. Dr. Lees has received personal compensation for activities with Allon, Genus, Novartis, Teva Neuroscience, Meda, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline Inc., Ipsen, Lundbeck Research USA Inc., Allergan Inc., Orion, BIAL, Noscira and Roche Diagnostics Corp. Dr. Lees has received research support from the PSP Association, Weston Trust. Dr. Alegria has nothing to disclose. Dr. Krack has nothing to disclose. Dr. Cormier has nothing to disclose. Dr. Lesage has nothing to disclose. Dr. Brice has received personal compensation for activities with the Wolfson Foundation. Dr. Heutink has nothing to disclose. Dr. Gasser has nothing to disclose. Dr. Morris has received personal compensation for activities with AbbVie, UCB Pharma, and Teva Neuroscience. Dr. Lubbe has nothing to disclose. Dr. Majounie has nothing to disclose. Dr. Gibbs has nothing to disclose. Dr. Singleton has nothing to disclose. Dr. Hardy has nothing to disclose. Dr. Klebe has nothing to disclose. Dr. Bhatia has received personal compensation for activities with UCB Pharma, Novartis, and Ipsen as a speaker. Dr. Wood has nothing to disclose. Dr. International Parkinson9s Disease Genomics Consort has nothing to disclose." @default.
• W2415798049 created "2016-06-24" @default.
• W2415798049 creator A5000164275 @default.
• W2415798049 creator A5001664752 @default.
• W2415798049 creator A5005744752 @default.
• W2415798049 creator A5013166591 @default.
• W2415798049 creator A5013166645 @default.
• W2415798049 creator A5013639132 @default.
• W2415798049 creator A5014599513 @default.
• W2415798049 creator A5015186029 @default.
• W2415798049 creator A5023361389 @default.
• W2415798049 creator A5025710654 @default.
• W2415798049 creator A5026007088 @default.
• W2415798049 creator A5026046026 @default.
• W2415798049 creator A5026046934 @default.
• W2415798049 creator A5031587496 @default.
• W2415798049 creator A5034150523 @default.
• W2415798049 creator A5034219333 @default.
• W2415798049 creator A5034531104 @default.
• W2415798049 creator A5036127424 @default.
• W2415798049 creator A5036706411 @default.
• W2415798049 creator A5041543470 @default.
• W2415798049 creator A5046150517 @default.
• W2415798049 creator A5048171462 @default.
• W2415798049 creator A5053419046 @default.
• W2415798049 creator A5057064101 @default.
• W2415798049 creator A5057989264 @default.
• W2415798049 creator A5062015847 @default.
• W2415798049 creator A5063335320 @default.
• W2415798049 creator A5063939364 @default.
• W2415798049 creator A5067744605 @default.
• W2415798049 creator A5068543675 @default.
• W2415798049 creator A5071626950 @default.
• W2415798049 creator A5071831090 @default.
• W2415798049 creator A5072542068 @default.
• W2415798049 creator A5074313850 @default.
• W2415798049 creator A5079422770 @default.
• W2415798049 creator A5080641977 @default.
• W2415798049 creator A5082436384 @default.
• W2415798049 creator A5083714901 @default.
• W2415798049 creator A5084783422 @default.
• W2415798049 creator A5084992744 @default.
• W2415798049 creator A5091292094 @default.
• W2415798049 date "2014-04-08" @default.
• W2415798049 modified "2023-10-18" @default.
• W2415798049 title "Mutations in the GCH1 Gene Are Associated with Parkinson Disease (S17.001)" @default.
• W2415798049 hasPublicationYear "2014" @default.
• W2415798049 type Work @default.
• W2415798049 sameAs 2415798049 @default.
• W2415798049 citedByCount "0" @default.
• W2415798049 crossrefType "journal-article" @default.
• W2415798049 hasAuthorship W2415798049A5000164275 @default.
• W2415798049 hasAuthorship W2415798049A5001664752 @default.
• W2415798049 hasAuthorship W2415798049A5005744752 @default.
• W2415798049 hasAuthorship W2415798049A5013166591 @default.
• W2415798049 hasAuthorship W2415798049A5013166645 @default.
• W2415798049 hasAuthorship W2415798049A5013639132 @default.
• W2415798049 hasAuthorship W2415798049A5014599513 @default.
• W2415798049 hasAuthorship W2415798049A5015186029 @default.
• W2415798049 hasAuthorship W2415798049A5023361389 @default.
• W2415798049 hasAuthorship W2415798049A5025710654 @default.
• W2415798049 hasAuthorship W2415798049A5026007088 @default.
• W2415798049 hasAuthorship W2415798049A5026046026 @default.
• W2415798049 hasAuthorship W2415798049A5026046934 @default.
• W2415798049 hasAuthorship W2415798049A5031587496 @default.
• W2415798049 hasAuthorship W2415798049A5034150523 @default.
• W2415798049 hasAuthorship W2415798049A5034219333 @default.
• W2415798049 hasAuthorship W2415798049A5034531104 @default.
• W2415798049 hasAuthorship W2415798049A5036127424 @default.
• W2415798049 hasAuthorship W2415798049A5036706411 @default.
• W2415798049 hasAuthorship W2415798049A5041543470 @default.
• W2415798049 hasAuthorship W2415798049A5046150517 @default.
• W2415798049 hasAuthorship W2415798049A5048171462 @default.
• W2415798049 hasAuthorship W2415798049A5053419046 @default.
• W2415798049 hasAuthorship W2415798049A5057064101 @default.
• W2415798049 hasAuthorship W2415798049A5057989264 @default.
• W2415798049 hasAuthorship W2415798049A5062015847 @default.
• W2415798049 hasAuthorship W2415798049A5063335320 @default.
• W2415798049 hasAuthorship W2415798049A5063939364 @default.
• W2415798049 hasAuthorship W2415798049A5067744605 @default.
• W2415798049 hasAuthorship W2415798049A5068543675 @default.
• W2415798049 hasAuthorship W2415798049A5071626950 @default.
• W2415798049 hasAuthorship W2415798049A5071831090 @default.
• W2415798049 hasAuthorship W2415798049A5072542068 @default.
• W2415798049 hasAuthorship W2415798049A5074313850 @default.
• W2415798049 hasAuthorship W2415798049A5079422770 @default.
• W2415798049 hasAuthorship W2415798049A5080641977 @default.
• W2415798049 hasAuthorship W2415798049A5082436384 @default.
• W2415798049 hasAuthorship W2415798049A5083714901 @default.
• W2415798049 hasAuthorship W2415798049A5084783422 @default.
• W2415798049 hasAuthorship W2415798049A5084992744 @default.
• W2415798049 hasAuthorship W2415798049A5091292094 @default.
• W2415798049 hasConcept C104317684 @default.
• W2415798049 hasConcept C118552586 @default.
• W2415798049 hasConcept C12125453 @default.
• W2415798049 hasConcept C126322002 @default.
• W2415798049 hasConcept C137183658 @default.
• W2415798049 hasConcept C16671776 @default.
• W2415798049 hasConcept C2776525014 @default.
• W2415798049 hasConcept C2776755682 @default.

• next